VOYA Investment Management’s UroGen Pharma URGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$782K	Sell	43,498 -33,264	-43%	-$667K	﹤0.01%	1546
2025 Q4	$1.8M	Sell	76,762 -6,849	-8%	-$149K	﹤0.01%	1254
2025 Q3	$1.67M	Buy	83,611 +23,297	+39%	+$418K	﹤0.01%	1307
2025 Q2	$826K	Buy	60,314 +50,222	+498%	+$482K	﹤0.01%	1654
2025 Q1	$112K	Sell	10,092 -1,153	-10%	-$12.3K	﹤0.01%	2413
2024 Q4	$120K	Sell	11,245 -422	-4%	-$5.05K	﹤0.01%	2538
2024 Q3	$148K	Buy	11,667 +49	+0.4%	+$727	﹤0.01%	2564
2024 Q2	$195K	Buy	+11,618	New	+$165K	﹤0.01%	2486
2024 Q1	–	Sell	-11,080	Closed	-$166K	–	2888
2023 Q4	$166K	Buy	+11,080	New	+$144K	﹤0.01%	2629
2021 Q4	–	Sell	-148,439	Closed	-$2.5M	–	2822
2021 Q3	$2.5M	Sell	148,439 -12,082	-8%	-$192K	0.01%	1076
2021 Q2	$2.45M	Sell	160,521 -5,831	-4%	-$105K	﹤0.01%	1111
2021 Q1	$3.24M	Sell	166,352 -181,515	-52%	-$3.85M	0.01%	986
2020 Q4	$6.27M	Sell	347,867 -31,004	-8%	-$650K	0.01%	738
2020 Q3	$7.31M	Buy	378,871 +89,982	+31%	+$2.04M	0.02%	624
2020 Q2	$7.55M	Buy	288,889 +101,470	+54%	+$2.48M	0.02%	616
2020 Q1	$3.34M	Buy	187,419 +67,377	+56%	+$1.82M	0.01%	805
2019 Q4	$4M	Buy	+120,042	New	+$3.28M	0.01%	871
2019 Q3	–	Sell	-6,689	Closed	-$240K	–	2574
2019 Q2	$240K	Buy	+6,689	New	+$247K	﹤0.01%	2202